Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Browse archives for older articles from 2016 , 2015 , 2014 (all articles may be found in search)

Did you know how medwireNews writes our articles?


Date Title Topic
17 Dec 2018 Ixazomib ‘Additional Option’ For Multiple Myeloma Post-Transplant Maintenance Plasma Cell Dyscrasias - Anticancer Agents
14 Dec 2018 Long-Term Survival Benefit Of Radical Prostatectomy For Localised Prostate Cancer Characterised Prostate Cancer - Surgical Oncology
13 Dec 2018 Patient-Reported Outcomes Of IMPORT LOW Trial Revealed Breast Cancer - Complications/Toxicities of Treatment - Radiation Oncology
12 Dec 2018 Caution Warranted Regarding Alternative Controls To Assess HER2 Amplification Status Breast Cancer - Pathology/Molecular Biology
11 Dec 2018 Rare Haematological irAEs Reported For PD-1, PD-L1 Inhibitor Use Immunotherapy - Complications/Toxicities of Treatment
10 Dec 2018 Recurrent Glioblastoma OS Better With Regorafenib Than Lomustine Central Nervous System Malignancies - Anticancer Agents
07 Dec 2018 Direct Oral Anticoagulants Show Promise For Preventing VTE In Cancer Patients Supportive Measures
06 Dec 2018 Genetic Mechanism Of Venetoclax Resistance In CLL Patients Identified Haematological Malignancies - Leukaemia - Translational Research - Anticancer Agents
06 Dec 2018 Shorter Chemotherapy Course Feasible For Younger DLBCL Patients Haematological Malignancies - Lymphomas - Anticancer Agents
05 Dec 2018 2-Year ZUMA-1 Results Add Support For Axicabtagene Ciloleucel In Refractory Large B-Cell Lymphoma Haematological Malignancies - Lymphomas - Immunotherapy
04 Dec 2018 High Response Rates With Tisagenlecleucel In Adult Refractory DLBCL Patients Haematological Malignancies - Lymphomas - Immunotherapy
03 Dec 2018 Ibrutinib Regimens Achieve ‘Superior’ PFS For Treatment-Naïve CLL in Older Patients Leukaemia - Anticancer Agents - Geriatric Oncology
30 Nov 2018 Low Risk Of Intracranial Malignancy After Stereotactic Radiosurgery Central Nervous System Malignancies - Complications/Toxicities of Treatment - Radiation Oncology
29 Nov 2018 Regorafenib Shows ‘Clinically Meaningful’ Activity For Metastatic Osteosarcoma Bone Sarcomas - Anticancer Agents
28 Nov 2018 MRI-Targeted Prostate Biopsy Complements Systematic Biopsy Prostate Cancer - Imaging - Surgical Oncology